US EditionJ&J Faces Jury in Antitrust Battle Over Catheter Tying Policy - USA Herald
Summary by USA Herald
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
J&J Faces Jury in Antitrust Battle Over Catheter Tying Policy - USA Herald
In a high-stakes trial underway in the U.S. District Court for the Central District of California, Innovative Health CEO Rick Ferreira testified that a tying policy implemented by Johnson & Johnson’s unit, Biosense Webster, significantly harmed his company’s business, marking a key moment in the ongoing J&J catheter tying policy antitrust case. Ferreira, who founded
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
